Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Structure-Guided Discovery of Neuroprotective Kromycin-Type Macrolides from Streptomyces narbonensis sp.

Created on 19 Jun 2026

Authors

Ziheng Jing, Bingya Jiang, Weikang Li, Chenhui Zhang, Jingwen Xu, Tianxiang Zhang, Donglin Liu, Liyan Yu, Duqiang Luo, Zhengyan Guo

Published in

Journal of natural products. Jun 19, 2026. Epub Jun 19, 2026.

Abstract

Six new kromycin-type macrolides, kromycins B-G (1-6), and with the known kromycin A (7), were isolated from Streptomyces narbonensis sp. CPCC 206470 guided by the Global Natural Products Social Molecular Networking (GNPS) analysis. Their structures were comprehensively established by extensive spectroscopic analyses, time-dependent density functional theory electronic circular dichroism (TDDFT-ECD) comparison, and single-crystal X-ray diffraction analysis. These compounds represent a structurally distinct subclass of 14-membered macrolides. Compound 7 exhibited substantial neuroprotective activity by inhibiting Aβ42 aggregation and ameliorating oxidative stress and neuroinflammation in N2a neuronal cells. It enhanced antioxidant enzyme activities (SOD and CAT) and suppressed nitric oxide production. Genomic analysis identified a pikromycin-related biosynthetic gene cluster in the producing strain. This study expands the chemical diversity of kromycin-type natural products and highlights their potential as multitarget therapeutic agents for neurodegenerative diseases.

PMID:
42319266
Bibliographic data and abstract were imported from PubMed on 19 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement